急性呼吸窘迫综合征亚型中的肺泡生物标志物特征
该研究为一项随机对照试验的二次分析,纳入5个北美ICU中88例ARDS发病48小时内接受有创机械通气的成人患者,无干预。用既往验证的逻辑回归模型将57例分类为低炎症型、31例为高炎症型;14种BALF生物标志物中仅IL-6和G-CSF在高炎症型较高,但经多重假设检验后差异不稳健。对14种BALF标志物进行潜在类别分析识别出两个肺泡特征分离良好的类别,类别2(n=63)的IL-6、vWF、sPD-1、中性粒细胞百分比等炎症标志物显著高于类别1(n=25),且与血浆来源类别重叠极少,并与肺疾病临床严重度相关(类别2 PaO2/FiO2更低、通气参数不同),而血浆类别仅与非肺器官功能障碍相关。
要点
- 高炎症与低炎症ARDS亚型在肺泡生物标志物上无显著差异,IL-6和G-CSF的差异经多重假设检验后不稳健。
- 基于14种BALF标志物的潜在类别分析识别出两个类别:类别2(n=63)炎症标志物(IL-6、vWF、sPD-1、中性粒细胞百分比等)显著高于类别1(n=25)。
- BALF衍生类别与血浆衍生高/低炎症类别重叠极少,两个血浆类别多数落入BALF类别2且BALF标志物高。
- BALF类别2与肺疾病临床严重度相关:PaO2/FiO2更低、通气参数不同;血浆类别仅与非肺器官功能障碍相关。
- 作者认为用BALF测量识别ARDS亚组是补充血浆信息的新方法,可能有助于肺靶向治疗试验的富集策略。
适用人群与场景
- 成人(n=88)ARDS发病48小时内接受有创机械通气的患者。
诊断标准与关键阈值
- 使用既往验证的逻辑回归模型将患者分类为低炎症型(n=57)和高炎症型(n=31)。
- 对14种BALF生物标志物进行潜在类别分析,识别出类别1(n=25)和类别2(n=63)。
研究设计与关键结果
- 研究类型:随机对照试验(测试omega-3脂肪酸治疗ARDS)的二次分析;5个北美ICU;成人n=88,ARDS发病48小时内接受有创机械通气;无干预。
- 高炎症型(n=31)与低炎症型(n=57)比较:14种BALF生物标志物中,白介素-6和粒细胞集落刺激因子在高炎症型更高,但经多重假设检验后差异不稳健。
- BALF潜在类别分析:类别2(n=63)的白介素-6、血管性血友病因子、可溶性程序性细胞死亡受体-1、中性粒细胞百分比及其他炎症标志物显著高于类别1(n=25)。
- BALF衍生类别与血浆衍生高/低炎症类别重叠极少,两个血浆类别多数落入BALF类别2且BALF标志物高。
- BALF衍生类别与肺疾病临床严重度相关:类别2的PaO2/FiO2更低、通气参数不同;血浆衍生类别仅与非肺器官功能障碍相关。
证据类型、等级与局限
- 证据类型:随机对照试验的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,用BALF测量识别ARDS亚组是补充血浆信息的新方法,可能有助于肺靶向治疗试验的富集策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: We sought to determine whether hyperinflammatory acute respiratory distress syndrome (ARDS) and hypoinflammatory ARDS, which have been associated with differences in plasma biomarkers and mortality risk, also display differences in bronchoalveolar lavage (BALF) biomarker profiles. We then described the relationship between hyperinflammatory ARDS and hypoinflammatory ARDS to novel subphenotypes derived using BALF biomarkers.
DESIGN: Secondary analysis of a randomized control trial testing omega-3 fatty acids for the treatment of ARDS.
SETTING: Five North American intensive care units.
PATIENTS: Adults (n = 88) on invasive mechanical ventilation within 48 hours of ARDS onset.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We classified 57 patients as hypoinflammatory and 31 patients as hyperinflammatory using a previously validated logistic regression model. Of 14 BALF biomarkers analyzed, interleukin-6 and granulocyte colony stimulating factor were higher among patients with hyperinflammatory ARDS compared with hypoinflammatory ARDS, though the differences were not robust to multiple hypothesis testing. We then performed a de novo latent class analysis of the 14 BALF biomarkers to identify two classes well separated by alveolar profiles. Class 2 (n = 63) displayed significantly higher interleukin-6, von Willebrand factor, soluble programmed cell death receptor-1, % neutrophils, and other biomarkers of inflammation compared with class 1 (n = 25). These BALF-derived classes had minimal overlap with the plasma-derived hyperinflammatory and hypoinflammatory classes, and the majority of both plasma-derived classes were in BALF-derived class 2 and characterized by high BALF biomarkers. Additionally, the BALF-derived classes were associated with clinical severity of pulmonary disease, with class 2 exhibiting lower Pao2 to Fio2 and distinct ventilatory parameters, unlike the plasma-derived classes, which were only related to nonpulmonary organ dysfunction.
CONCLUSIONS: Hyperinflammatory and hypoinflammatory ARDS subphenotypes did not display significant differences in alveolar biologic profiles. Identifying ARDS subgroups using BALF measurements is a unique approach that complements information obtained from plasma, with potential to inform enrichment strategies in trials of lung-targeted therapies.
参考来源
- Sathe NA, Morrell ED, Bhatraju PK, et al. Alveolar Biomarker Profiles in Subphenotypes of the Acute Respiratory Distress Syndrome. Crit Care Med. 2022. PMID: 36519995. doi:10.1097/CCM.0000000000005704
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。